需要醫師參與解讀的頁面這個主題可能涉及檢查或影像解讀、神經、心臟、血液、肝、腎、肺、手術、用藥或複雜基礎病情況。BioConst 只做解釋，不提供個人判斷或處置建議。
這是什麼
Liver cancer context belongs with structural imaging and oncology-aware review.[1,2,3]
大家可能感知到什麼
- Liver cancer can start in the liver, and chronic liver disease can change risk context.[1,2,3]
- Cirrhosis and viral hepatitis can be relevant upstream contexts.[1,2,3]
為什麼會發生
- Risk context can include chronic hepatitis, cirrhosis, metabolic liver disease, and other liver conditions.[1,2,3]
- Diagnosis and staging are oncology and hepatology territory.[1,2,3]
臨床應對方向
- Clinical teams may use history, exam, labs, imaging, and specialist review depending on liver cancer context.[1,2,3]
- BioConst explains the map and does not diagnose, rank urgency, choose tests, or recommend treatment.[1,2,3]
常見誤區
- A liver panel does not diagnose liver cancer.[1,2,3]
- A mass, nodule, or imaging phrase needs clinician review.[1,2,3]
- Cancer pages require oncology-aware boundaries.[1,2,3]